JP2013525355A5 - - Google Patents

Download PDF

Info

Publication number
JP2013525355A5
JP2013525355A5 JP2013506202A JP2013506202A JP2013525355A5 JP 2013525355 A5 JP2013525355 A5 JP 2013525355A5 JP 2013506202 A JP2013506202 A JP 2013506202A JP 2013506202 A JP2013506202 A JP 2013506202A JP 2013525355 A5 JP2013525355 A5 JP 2013525355A5
Authority
JP
Japan
Prior art keywords
formula
compound
optionally substituted
alkyl
halo
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2013506202A
Other languages
English (en)
Japanese (ja)
Other versions
JP2013525355A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2011/032822 external-priority patent/WO2011133442A1/en
Publication of JP2013525355A publication Critical patent/JP2013525355A/ja
Publication of JP2013525355A5 publication Critical patent/JP2013525355A5/ja
Pending legal-status Critical Current

Links

JP2013506202A 2010-04-19 2011-04-18 チアゾリジンジオン化合物の新規合成 Pending JP2013525355A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US32550210P 2010-04-19 2010-04-19
US61/325,502 2010-04-19
US32749810P 2010-04-23 2010-04-23
US61/327,498 2010-04-23
PCT/US2011/032822 WO2011133442A1 (en) 2010-04-19 2011-04-18 Novel synthesis for thiazolidinedione compounds

Publications (2)

Publication Number Publication Date
JP2013525355A JP2013525355A (ja) 2013-06-20
JP2013525355A5 true JP2013525355A5 (enExample) 2014-04-24

Family

ID=44148625

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2013506202A Pending JP2013525355A (ja) 2010-04-19 2011-04-18 チアゾリジンジオン化合物の新規合成

Country Status (15)

Country Link
US (1) US8937182B2 (enExample)
EP (1) EP2560956B1 (enExample)
JP (1) JP2013525355A (enExample)
KR (1) KR101781665B1 (enExample)
CN (1) CN102947269B (enExample)
AU (1) AU2011242956B2 (enExample)
CA (1) CA2796437C (enExample)
DK (1) DK2560956T3 (enExample)
ES (1) ES2610623T3 (enExample)
HU (1) HUE030263T2 (enExample)
MX (1) MX2012012092A (enExample)
NZ (1) NZ602883A (enExample)
PL (1) PL2560956T3 (enExample)
RU (1) RU2012148908A (enExample)
WO (1) WO2011133442A1 (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2802733C (en) * 2010-06-24 2017-11-21 Alkermes Pharma Ireland Limited Prodrugs of nh-acidic compounds: ester, carbonate, carbamate and phosphonate derivatives
WO2012021476A1 (en) * 2010-08-10 2012-02-16 Metabolic Solutions Development Company, Llc Novel synthesis for thiazolidinedione compounds
RU2594725C2 (ru) 2010-08-10 2016-08-20 МЕТАБОЛИК СОЛЮШНЗ ДЕВЕЛОПМЕНТ КОМПАНИ, ЭлЭлСи Синтез соединений тиазолидиндиона
TWI773657B (zh) 2015-12-18 2022-08-11 美商亞德利克斯公司 作爲非全身tgr5促效劑之經取代之4-苯基吡啶化合物
US12084472B2 (en) 2015-12-18 2024-09-10 Ardelyx, Inc. Substituted 4-phenyl pyridine compounds as non-systemic TGR5 agonists
US20210038566A1 (en) 2018-02-08 2021-02-11 Enyo Pharma Use of modulators of neet proteins for the treatment of infection

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1003445B (zh) 1984-10-03 1989-03-01 武田药品工业株式会社 噻唑烷二酮衍生物,其制备方法和用途
US5143930A (en) 1990-02-07 1992-09-01 Sankyo Company, Limited Thiazolidine derivatives with anti-diabetic activity, their preparation and their use
SK109993A3 (en) * 1991-04-11 1994-12-07 Upjohn Co Thiazolidinedione derivatives producing and use thereof
NO302471B1 (no) * 1991-12-26 1998-03-09 Sankyo Co Tiazolidinforbindelser og farmasöytisk preparat
JPH07188227A (ja) * 1993-12-24 1995-07-25 Japan Tobacco Inc チアゾリジン誘導体及びオキサゾール誘導体
SE9702305D0 (sv) 1997-06-17 1997-06-17 Astra Ab New thiazolidinedione, oxazolidinedione and oxadiazolidinedione derivatives
AP869A (en) * 1998-01-05 2000-09-04 Pfizer 2,3-Substituted indole compounds as anti-inflammatory and analgesic agents.
US7407978B2 (en) 1999-04-06 2008-08-05 Theracos, Inc. Heterocyclic analogs of diphenylethylene compounds
US6768008B2 (en) * 2000-04-24 2004-07-27 Aryx Therapeutics Materials and methods for the treatment of diabetes, hyperlipidemia, hypercholesterolemia, and atherosclerosis
FR2817144B1 (fr) 2000-11-29 2003-01-03 Micro Mega Sa Sequence d'instruments canalaires pour l'execution d'un protocole operatoire d'endodontie
WO2003029251A1 (en) * 2001-09-28 2003-04-10 Biocon Limited Novel process for the synthesis of thiazolidinedione derivatives
FR2861069B1 (fr) 2003-10-17 2005-12-09 Galderma Res & Dev NOUVEAUX LIGANDS ACTIVATEURS DES RECEPTEURS RARs, UTILISATION EN MEDECINE HUMAINE AINSI QU'EN COSMETIQUE
EP2001470A2 (en) 2006-03-16 2008-12-17 Metabolic Solutions Development Company Combination therapies of thiazolidinedione analogues
MX356584B (es) 2006-03-16 2018-06-05 Metabolic Solutions Dev Co Analogos de tiazolidindiona para el tratamiento de enfermedad mediada por inflamacion metabolica.
PL2001469T3 (pl) 2006-03-16 2012-10-31 Metabolic Solutions Dev Co Llc Analogi tiazolidynodionu
AU2007326395B2 (en) * 2006-12-01 2012-10-11 Msd K.K. Novel phenyl-isoxazol-3-ol derivative
WO2008118327A1 (en) * 2007-03-23 2008-10-02 University Of Toledo Conformationally restrained epothilone analogues as anti-leukemic agents
NZ597381A (en) * 2007-09-14 2013-03-28 Metabolic Solutions Dev Co Llc Thiazolidinedione analogues for the treatment of diabetes and inflammatory diseases
WO2009148195A1 (en) * 2008-06-02 2009-12-10 Daebong Ls, Ltd. 5-(4-hydroxybenzyl)thiazolidine-2,4-dione as intermediate for synthesis of thiazolidinedione based compounds and process for preparing the same
WO2011133441A2 (en) 2010-04-19 2011-10-27 Metabolic Solutions Development Company Novel synthesis for thiazolidinedione compounds
RU2594725C2 (ru) 2010-08-10 2016-08-20 МЕТАБОЛИК СОЛЮШНЗ ДЕВЕЛОПМЕНТ КОМПАНИ, ЭлЭлСи Синтез соединений тиазолидиндиона
WO2012021476A1 (en) 2010-08-10 2012-02-16 Metabolic Solutions Development Company, Llc Novel synthesis for thiazolidinedione compounds

Similar Documents

Publication Publication Date Title
JP2013525355A5 (enExample)
CA2796872A1 (en) Novel synthesis for thiazolidinedione compounds
US10442825B2 (en) Method of hydrosilylation implementing an organic catalyst derived from germylene
JP2010510976A5 (enExample)
JP2008511659A5 (enExample)
JP2012526842A5 (enExample)
CY1116945T1 (el) Παραγωγα ινδολιζινης, διεργασια για την παρασκευη αυτης και θεραπευτικη χρηση αυτης
RU2013147400A (ru) Способ получения производных кето-бензофурана
JP6938048B2 (ja) オリゴシロキサン、及びシリルアセタールからのオリゴシロキサンの製造方法
RU2012148908A (ru) Новый синтез соединений тиазолидиндиона
JP2010531855A5 (enExample)
JP6797268B2 (ja) 新規なヒドロキシフェニルボロン酸エステルとその製造方法、およびヒドロキシビフェニル化合物の製造法
KR101249361B1 (ko) 고순도 트리스(트리알킬실릴)포스파이트의 제조 방법
EP2876111B1 (en) Composition containing nitrogen-containing organoxysilane compound and method for making the same
JP2013525473A5 (enExample)
JP2014009330A5 (enExample)
JP2012530113A5 (enExample)
Singh et al. Schiff bases of N-(2-aminoethyl)-3-aminopropyltrimethoxysilane and its silatranes: Synthesis and characterization
JP2012006844A (ja) アルコキシヒドロシランの製造方法
WO2021085535A1 (ja) 化合物及びその製造方法
JP2019532071A5 (enExample)
Gholivand et al. Phosphoramides bearing isoxazole derivative: spectroscopic and structural characterization, study of hydrogen-bonding interactions and two lanthanide complexes (LnIII= Ce and Eu)
JP2011256120A (ja) オルガノアミノシラン化合物の製造方法
JP2012031413A5 (enExample)
JP2008515883A5 (enExample)